Amgen (AMGN) News Today

Groupama Asset Managment bought a new position in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 38,024 shares of the medical research c

Chilton Investment Co. Inc. grew its holdings in Amgen Inc. (NASDAQ:AMGN - Free Report) by 421.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,778 shares of the medical research company's stock after purchasing an

RMB Capital Management LLC reduced its holdings in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) by 5.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 54,695 shares of the medical research company's stock after

Bridgewater Associates LP increased its holdings in Amgen Inc. (NASDAQ:AMGN - Free Report) by 421.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 144,483 shares of the medical research compa

Amgen Inc. (NASDAQ:AMGN - Free Report) - Equities researchers at William Blair reduced their FY2025 earnings estimates for Amgen in a research report issued on Wednesday, June 5th. William Blair analyst M. Phipps now expects that the medical research company will post earnings per share of $19.15

Allen Wealth Management LLC bought a new position in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 2,869 shares of the medical research co

Westwood Holdings Group Inc. boosted its position in Amgen Inc. (NASDAQ:AMGN - Free Report) by 10.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 80,189 shares of the medical rese

Schroder Investment Management Group raised its stake in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) by 19.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 488,451 shares of the

Pinebridge Investments L.P. boosted its stake in Amgen Inc. (NASDAQ:AMGN - Free Report) by 66.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 120,401 shares of the medical research company's stock a

One fascinating sector to invest in is the biotech sector which includes companies involved in the research and development of therapeutics and vaccines

Public Employees Retirement Association of Colorado lifted its stake in Amgen Inc. (NASDAQ:AMGN - Free Report) by 792.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 79,695 shares of the medical research company's stock after buying an

Bell Asset Management Ltd decreased its position in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) by 31.8% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 20,280 shares of the medical research company's stock after selling 9,435 shares during the perio

The Manufacturers Life Insurance Company trimmed its holdings in Amgen Inc. (NASDAQ:AMGN - Free Report) by 1.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 586,841 shares of the medical research co

Eagle Asset Management Inc. raised its position in Amgen Inc. (NASDAQ:AMGN - Free Report) by 35.4% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 483,831 shares of the medical research company's stock after purchasing an additional 1

Amgen Inc. (NASDAQ:AMGN - Get Free Report) saw a large increase in short interest in the month of May. As of May 15th, there was short interest totalling 10,250,000 shares, an increase of 5.5% from the April 30th total of 9,720,000 shares. Currently, 1.9% of the company's shares are sold short. Based on an average daily trading volume, of 2,720,000 shares, the short-interest ratio is currently 3.8 days.

Lloyd Advisory Services LLC. reduced its position in Amgen Inc. (NASDAQ:AMGN - Free Report) by 83.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 826 shares of the medical research company's stock after selling 4,131 shares

TFO Wealth Partners LLC grew its position in Amgen Inc. (NASDAQ:AMGN - Free Report) by 4,503.2% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 7,135 shares of the medical research company's stock after acquiring an additional 6,980 shares during the period.

TD Asset Management Inc trimmed its holdings in Amgen Inc. (NASDAQ:AMGN - Free Report) by 2.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 562,812 shares of the medical research company's stock after selling 13

Legacy Advisors LLC lowered its position in Amgen Inc. (NASDAQ:AMGN - Free Report) by 21.3% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 11,155 shares of the medical research company's stock after selling 3,021 shares during the period.

Bell & Brown Wealth Advisors LLC bought a new stake in Amgen Inc. (NASDAQ:AMGN - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 9,323 shares of the medical research company's sto

Amgen Inc. (NASDAQ:AMGN - Free Report) - Equities research analysts at Zacks Research reduced their Q2 2024 earnings per share (EPS) estimates for Amgen in a report issued on Thursday, May 23rd. Zacks Research analyst S. Ganoria now forecasts that the medical research company will earn $4.85 per

Hudson Value Partners LLC lifted its stake in Amgen Inc. (NASDAQ:AMGN - Free Report) by 176.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 13,330 shares of the medical research company's stock after buyin

Shares of Amgen Inc. (NASDAQ:AMGN - Get Free Report) have been given an average recommendation of "Moderate Buy" by the twenty-one analysts that are currently covering the stock, Marketbeat.com reports. Ten analysts have rated the stock with a hold recommendation and eleven have assigned a buy rec

Advisory Services Network LLC lessened its holdings in Amgen Inc. (NASDAQ:AMGN - Free Report) by 12.3% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 20,455 shares of the medical research company's stock afte

Primecap Management Co. CA lowered its position in Amgen Inc. (NASDAQ:AMGN - Free Report) by 1.0% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 14,591,468 shares of the medical research company's stock after selling 140,990 shares during the qua

Amgen Inc. (NASDAQ:AMGN - Free Report) - Analysts at Zacks Research increased their Q3 2024 earnings per share estimates for shares of Amgen in a report released on Thursday, May 23rd. Zacks Research analyst S. Ganoria now anticipates that the medical research company will earn $5.09 per share fo

Greylin Investment Management Inc cut its holdings in Amgen Inc. (NASDAQ:AMGN - Free Report) by 48.1% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 15,860 shares of the medical research company's stock after selling